Results 61 to 70 of about 288 (74)

Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection. [PDF]

PLoS One, 2020
Faure Bardon V, Peytavin G, Lê MP, Guilleminot T, Elefant E, Stirnemann J, Leruez-Ville M, Ville Y.   +7 more
europepmc   +1 more source

[Phase Ⅲ, multicenter, randomized, double-blinded, positive-controlled trial on the efficacy and safety of maribavir compared with valganciclovir in the treatment of post-transplant cytomegalovirus infection: Subgroup analysis of AURORA Trial in the Chinese population]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xuan L, Huang H, Xu LP, Fu YW, Chen F, Wang Y, Wang SQ, Dong L, Wu JY, Wu DP.   +9 more
europepmc   +1 more source

Correction: Androgen-Sensitized Apoptosis of HPr-1AR Human Prostate Epithelial Cells. [PDF]

PLoS One, 2019
Chen C, Dienhart JA, Bolton EC.
europepmc   +1 more source

Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. [PDF]

J Infect Dis
Chou S, Alain S, Cervera C, Chemaly RF, Kotton CN, Lundgren J, Papanicolaou GA, Pereira MR, Wu JJ, Murray RA, Buss NE, Fournier M.   +11 more
europepmc   +1 more source

Impact of RNA polymerase I inhibitor CX-5461 on viral kinase-dependent and -independent cytomegalovirus replication. [PDF]

Antiviral Res, 2018
Westdorp KN, Terhune SS.
europepmc   +1 more source

The effective multiplicity of infection for HCMV depends on the activity of the cellular 20S proteasome. [PDF]

J Virol
Cataldo KM, Roche KL, Monti CE, Dash RK, Murphy EA, Terhune SS.   +5 more
europepmc   +1 more source

[Maribavir treatment for refractory and drug-intolerant cytomegalovirus viremia and disease after allogeneic hematopoietic stem cell transplantation: a clinical analysis of 25 cases]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Ma W, Wei ZJ, Lu Y, Zhang JP, Sun RJ, Xiong M, Zhou JR, Dong L, Xue S, Cao XY.   +9 more
europepmc   +1 more source

Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus. [PDF]

Antiviral Res, 2018
Chou S, Ercolani RJ, Derakhchan K.
europepmc   +1 more source

Population pharmacokinetics and exposure-response relationships of maribavir in transplant recipients with cytomegalovirus infection. [PDF]

J Pharmacokinet Pharmacodyn
Song IH, Chen G, Hayes S, Farrell C, Jomphe C, Gosselin NH, Sun K.   +6 more
europepmc   +1 more source

TLP-mediated global transcriptional repression after double-strand DNA breaks slows down DNA repair and induces apoptosis. [PDF]

Sci Rep, 2019
Suzuki H, Okamoto-Katsuyama M, Suwa T, Maeda R, Tamura TA, Yamaguchi Y.   +5 more
europepmc   +1 more source